Inventor
BAUSS FRIEDER
DE12 patents
⚠️ This page may combine multiple inventors who share the name “BAUSS FRIEDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER MANNHEIM GMBH
6 patentsUS5538957AJul 23, 1996
Phosphonosuccinic acid derivatives, processes for their preparation and medicaments containing these compounds
BOEHRINGER MANNHEIM GMBH27 citations92
US5206253AApr 27, 1993
Disphosphonic acid derivatives, processes for their production and pharmaceutical preparations containing these compounds
BOEHRINGER MANNHEIM GMBH13 citations73
US5683994ANov 4, 1997
Phosphosuccinic acid derivatives, processes for the production thereof and pharmaceutical agents containing these compounds
BOEHRINGER MANNHEIM GMBH3 citations62
US5698541ADec 16, 1997
2,4-diphosphonoglutaric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
BOEHRINGER MANNHEIM GMBH1 citations51
US5627170AMay 6, 1997
Phosphonic acid compound containing heterocyclic substituents, pharmaceutical composition contains same and a method of treating calcium metabolism disturbance
BOEHRINGER MANNHEIM GMBH1 citations51
US5543561AAug 6, 1996
Acyclic amidine group-containing diphosphonic acid derivatives, processes for their preparation and medicaments containing these compounds
BOEHRINGER MANNHEIM GMBH1 citations51
HOFFMANN LA ROCHE
4 patentsUS7410957B2Aug 12, 2008
Method of treatment using bisphosphonic acid
HOFFMANN LA ROCHE36 citations90
US7192938B2Mar 20, 2007
Method of treatment using bisphosphonic acid
HOFFMANN LA ROCHE13 citations90
US9180185B2Nov 10, 2015
Combination therapy of anti-HER3 antibodies
HOFFMANN LA ROCHE13 citations82
US7718634B2May 18, 2010
Method of treatment using bisphosphonic acid
HOFFMANN LA ROCHE11 citations81
ROCHE DIAGNOSTICS GMBH
2 patentsUS6680307B1Jan 20, 2004
Use of ibandronate for promoting osseointegration of endoprostheses
ROCHE DIAGNOSTICS GMBH18 citations85
US6476008B1Nov 5, 2002
Use of diphosphonic acids or the physiologically acceptable salts or esters thereof in the preventive treatment of after-effects resulting from enlargement or replacement of the bladder
ROCHE DIAGNOSTICS GMBH0 citations42